Paris, France · Founded 2022 · Privately Held (backing)
Operator of a bioproduction platform intended to produce cheap and novel biopharmaceuticals. Kyron.bio is based in Paris, France and was founded in 2022. Its last reported valuation was $15 million in May 2025. It has raised $8.1 million.
Last reported valuation
$15.0M
Oct 2026
Priced at
—
Total raised
$8.1M
Last round
—
Cap table — not yet on record
Kyron.bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kyron.bio with a free account
·The complete investor list: 13 names
·Watch Kyron.bio: the Monday email on marks, rounds and moves
